WinstonWınston
Sintx Technologies logo

Sintx Technologies

SINT
22
Medical - Devices · Healthcare
Price
$1.66
+0.03 (+1.84%)
Market Cap
$6.8M
Exchange
NASDAQ Capital Market
Winston Score
22
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 9, 2026 · filings through Mar 31, 2026

Share count rising — dilution

+1022.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 247K (2021) → 2.8M (2025)

Sintx Technologies is a small medical materials company that makes products using silicon nitride, a tough ceramic material originally developed for industrial uses. The company focuses on using silicon nitride in medical implants, particularly spinal fusion devices, and is researching its use in antibacterial and antiviral applications. It sells to hospitals and surgical centers, primarily in the United States.

Sintx makes money by selling its silicon nitride-based medical devices and through research partnerships and licensing agreements. The company is very small, with a market cap near zero and deeply negative profit margins, meaning it spends far more than it earns. Its main competitive angle is its specialized knowledge of silicon nitride ceramics, which few other companies work with in medical settings. The biggest risk the company faces is running out of cash before it can grow its product sales enough to become profitable, which is a serious concern given its current financial losses.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+3.0% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+45.7% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$5M/ year

Declining (-12% vs prior year)

450.6% of revenue

25.0x the sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

16.5%ownership

Insiders own a meaningful stake in the company

Cash Runway

~2 months

$2M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Sintx Technologies has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
-3.2%
Thin — -3.2% gross margin
Operating Margin
-843.9%
Losing money on operations — -843.9%
ROCE
-85.6%
Weak — -85.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-37.9%
Shrinking sales (-37.9% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-961.5%
Burning cash (-961.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
3.14
Heavy debt load (3.14)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial